Clarus Therapeutics

United States
Attalla, Alabama, United States, 60062

Company profile

Clarus Therapeutics company profile

Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.

Business identity

Contact email
[email protected]
Phone number
847-562-4300
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$1M-$10M
Founded
2003-01-01, Year

Headquarters

Postal code
60062
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$112M
Last funding
Post IPO Equity / $30M / 2022-04-25
Last equity funding
Post IPO Equity / $30M
Investors
4
Lead investors
3
Founders
1
Articles
30
Exited on
2021-09-10

Founders and investors

Founders

Robert E. Dudley

Lead investors

C-Bridge CapitalH.I.G. CapitalThomas, McNerney & Partners

Investors

Armentum PartnersC-Bridge CapitalH.I.G. CapitalThomas, McNerney & Partners